ArticleAllergy, asthma & immunology research2025

Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A

Ruchong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.